Repurposing of FDA-approved drugs against active site and potential allosteric drug-binding sites of COVID-19 main protease

Merve Yuce, Erdem Cicek, Tugce Inan, Aslihan Basak Dag, Ozge Kurkcuoglu*, Fethiye Aylin Sungur*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

33 Citations (Scopus)

Fingerprint

Dive into the research topics of 'Repurposing of FDA-approved drugs against active site and potential allosteric drug-binding sites of COVID-19 main protease'. Together they form a unique fingerprint.

Keyphrases

Pharmacology, Toxicology and Pharmaceutical Science